These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 25491671)

  • 1. Peptide-mediated delivery: an overview of pathways for efficient internalization.
    Pae J; Pooga M
    Ther Deliv; 2014 Nov; 5(11):1203-22. PubMed ID: 25491671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PepFect15, a novel endosomolytic cell-penetrating peptide for oligonucleotide delivery via scavenger receptors.
    Lindberg S; Muñoz-Alarcón A; Helmfors H; Mosqueira D; Gyllborg D; Tudoran O; Langel U
    Int J Pharm; 2013 Jan; 441(1-2):242-7. PubMed ID: 23200958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a future for cell-penetrating peptides in oligonucleotide delivery?
    Lee SH; Castagner B; Leroux JC
    Eur J Pharm Biopharm; 2013 Sep; 85(1):5-11. PubMed ID: 23958313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling the Mechanisms of Peptide-Mediated Delivery of Nucleic Acids Using Electron Microscopy.
    Margus H; Juks C; Pooga M
    Methods Mol Biol; 2015; 1324():149-62. PubMed ID: 26202268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives.
    Patel LN; Zaro JL; Shen WC
    Pharm Res; 2007 Nov; 24(11):1977-92. PubMed ID: 17443399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide vectors for the nonviral delivery of nucleic acids.
    Hoyer J; Neundorf I
    Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of cellular internalization pathways for CPP-mediated oligonucleotide delivery.
    Guterstam P; Andaloussi SE; Langel U
    Methods Mol Biol; 2011; 683():219-30. PubMed ID: 21053133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo biodistribution and efficacy of peptide mediated delivery.
    Järver P; Mäger I; Langel Ü
    Trends Pharmacol Sci; 2010 Nov; 31(11):528-35. PubMed ID: 20828841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
    Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
    Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective capture of proteins inside living cells by antibodies indirectly linked to a novel cell-penetrating polymer-modified protein A derivative.
    Itakura S; Hama S; Ikeda H; Mitsuhashi N; Majima E; Kogure K
    FEBS J; 2015 Jan; 282(1):142-52. PubMed ID: 25315678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell penetrating peptides: efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules.
    Farkhani SM; Valizadeh A; Karami H; Mohammadi S; Sohrabi N; Badrzadeh F
    Peptides; 2014 Jul; 57():78-94. PubMed ID: 24795041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A non-covalent peptide-based strategy for ex vivo and in vivo oligonucleotide delivery.
    Crombez L; Morris MC; Heitz F; Divita G
    Methods Mol Biol; 2011; 764():59-73. PubMed ID: 21748633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PepFect14 peptide vector for efficient gene delivery in cell cultures.
    Veiman KL; Mäger I; Ezzat K; Margus H; Lehto T; Langel K; Kurrikoff K; Arukuusk P; Suhorutšenko J; Padari K; Pooga M; Lehto T; Langel Ü
    Mol Pharm; 2013 Jan; 10(1):199-210. PubMed ID: 23186360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-penetrating peptides: breaking through to the other side.
    Koren E; Torchilin VP
    Trends Mol Med; 2012 Jul; 18(7):385-93. PubMed ID: 22682515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetrating the cell membrane, thermal targeting and novel anticancer drugs: the development of thermally targeted, elastin-like polypeptide cancer therapeutics.
    Ryu JS; Kuna M; Raucher D
    Ther Deliv; 2014 Apr; 5(4):429-45. PubMed ID: 24856169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intelligent substance delivery into cells using cell-penetrating peptides.
    Tashima T
    Bioorg Med Chem Lett; 2017 Jan; 27(2):121-130. PubMed ID: 27956345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel cell-penetrating peptide-adaptors effect intracellular delivery and endosomal escape of protein cargos.
    Salerno JC; Ngwa VM; Nowak SJ; Chrestensen CA; Healey AN; McMurry JL
    J Cell Sci; 2016 Mar; 129(5):893-7. PubMed ID: 26801086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-penetrating peptides as a novel transdermal drug delivery system.
    Nasrollahi SA; Taghibiglou C; Azizi E; Farboud ES
    Chem Biol Drug Des; 2012 Nov; 80(5):639-46. PubMed ID: 22846609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide-based vectors: recent developments.
    Cerrato CP; Lehto T; Langel Ü
    Biomol Concepts; 2014 Dec; 5(6):479-88. PubMed ID: 25429600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and new strategies for therapeutic peptide delivery to the CNS.
    McGowan JW; Bidwell GL; Vig PJ
    Ther Deliv; 2015 Jul; 6(7):841-53. PubMed ID: 26228775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.